Literature DB >> 14626524

Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular disease.

R Keith Campbell1.   

Abstract

The prevalence of insulin resistance and type 2 diabetes is rapidly increasing, primarily because of rising rates of obesity and physical inactivity. Insulin resistance syndrome is a metabolic disorder that often leads to a cluster of serious clinical conditions, including type 2 diabetes and cardiovascular disease. Optimal management of diabetes requires not only tight glycemic control but also stringent management of cardiovascular risk factors. Because of their ready access to patients, pharmacists are well positioned to help detect and manage the many conditions associated with insulin resistance.

Entities:  

Mesh:

Year:  2003        PMID: 14626524

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  1 in total

1.  Community Pharmacists role in obesity treatment in Kuwait: a cross-sectional study.

Authors:  Abdelmoneim Awad; Mohammad Waheedi
Journal:  BMC Public Health       Date:  2012-10-11       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.